News

In the past three decades, reported incident cases and disability-adjusted life-years of bacterial sexually transmitted infections (STIs) have increased substantially worldwide. According to estimates from the Global Burden of Disease study, Chlamydia trachomatis (chlamydia), Neisseria gonorrhoeae (gonorrhoea), and Treponema pallidum (syphilis) resulted in approximately 350 million new STI cases and more than 400 000 disability-adjusted life-years in 2019.1 Although largely preventable and curable, untreated bacterial STIs can lead to severe complications such as pelvic inflammatory disease, adverse pregnancy outcomes, and infertility in women, and epididymitis, prostatitis, and urethral strictures in men, as well as increased susceptibility to other infections, including HIV, among both women and men.